Wei Chua

5.0k total citations
80 papers, 1.8k citations indexed

About

Wei Chua is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Wei Chua has authored 80 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 23 papers in Cancer Research. Recurrent topics in Wei Chua's work include Colorectal Cancer Treatments and Studies (18 papers), Cancer Genomics and Diagnostics (15 papers) and Colorectal Cancer Surgical Treatments (13 papers). Wei Chua is often cited by papers focused on Colorectal Cancer Treatments and Studies (18 papers), Cancer Genomics and Diagnostics (15 papers) and Colorectal Cancer Surgical Treatments (13 papers). Wei Chua collaborates with scholars based in Australia, Singapore and United States. Wei Chua's co-authors include Stephen Clarke, Kellie A. Charles, Vickie E. Baracos, Paul de Souza, Melissa M. Moore, Weng Ng, Therese M. Becker, Stephanie Lim, Kevin J. Spring and Yafeng Ma and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Wei Chua

71 papers receiving 1.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Wei Chua 1.2k 512 447 348 328 80 1.8k
Xuanzhang Huang 1.0k 0.9× 452 0.9× 503 1.1× 598 1.7× 370 1.1× 57 1.8k
Ruth Vera 1.3k 1.1× 283 0.6× 394 0.9× 357 1.0× 252 0.8× 102 1.8k
Yuan Tang 636 0.5× 339 0.7× 415 0.9× 345 1.0× 429 1.3× 209 1.8k
Som D. Mukherjee 968 0.8× 414 0.8× 499 1.1× 415 1.2× 560 1.7× 85 2.0k
Alain Gelibter 974 0.8× 333 0.7× 574 1.3× 193 0.6× 332 1.0× 100 1.4k
K. Syrigos 1.1k 1.0× 288 0.6× 638 1.4× 246 0.7× 388 1.2× 73 1.9k
Édouard Auclin 1.7k 1.4× 390 0.8× 1.1k 2.4× 212 0.6× 374 1.1× 127 2.4k
Pan Chi 1.0k 0.9× 611 1.2× 426 1.0× 635 1.8× 880 2.7× 237 2.3k
Daisuke Izumi 635 0.5× 399 0.8× 413 0.9× 573 1.6× 548 1.7× 64 1.7k
Howard M. Gross 1.4k 1.2× 530 1.0× 538 1.2× 272 0.8× 702 2.1× 55 2.6k

Countries citing papers authored by Wei Chua

Since Specialization
Citations

This map shows the geographic impact of Wei Chua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Chua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Chua more than expected).

Fields of papers citing papers by Wei Chua

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Chua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Chua. The network helps show where Wei Chua may publish in the future.

Co-authorship network of co-authors of Wei Chua

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Chua. A scholar is included among the top collaborators of Wei Chua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Chua. Wei Chua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hong, Martin, Jun Hee Hong, George Au‐Yeung, et al.. (2025). Application of Generative Artificial Intelligence for Physician and Patient Oncology Letters—AI-OncLetters. JCO Clinical Cancer Informatics. 9(9). e2400323–e2400323.
2.
Della‐Fiorentina, Stephen, et al.. (2024). Outcomes of intravesical Bacillus Calmette-Guerin in patients with non-muscle invasive bladder cancer: a retrospective study in Australia. SHILAP Revista de lepidopterología. 4. 1309532–1309532.
3.
Lin, Peter, et al.. (2024). Current state of theranostics in metastatic castrate‐resistant prostate cancer. Journal of Medical Imaging and Radiation Oncology. 68(4). 412–420. 1 indexed citations
5.
Ho, Vincent, Liping Chung, Kate Wilkinson, et al.. (2024). Microsatellite Instability Testing and Prognostic Implications in Colorectal Cancer. Cancers. 16(11). 2005–2005. 5 indexed citations
6.
Lim, Stephanie, Wei Chua, Weng Ng, et al.. (2023). Circulating Tumour Cell Associated MicroRNA Profiles Change during Chemoradiation and Are Predictive of Response in Locally Advanced Rectal Cancer. Cancers. 15(16). 4184–4184. 1 indexed citations
7.
Ho, Vincent, Liping Chung, Kate Wilkinson, et al.. (2023). Prognostic Significance of MRE11 Overexpression in Colorectal Cancer Patients. Cancers. 15(9). 2438–2438. 4 indexed citations
8.
Chua, Wei, Winnie Lam, L. Loh, et al.. (2023). Safety and efficacy of peptide receptor radionuclide therapy in patients with advanced pheochromocytoma and paraganglioma: A single‐institution experience and review of the literature. Journal of Neuroendocrinology. 35(12). e13349–e13349. 3 indexed citations
9.
Chua, Wei, Winnie Lam, Aaron Kian Ti Tong, et al.. (2023). Outcomes and prognostic predictors of Lu‐177 PSMA radioligand therapy in metastatic castration‐resistant prostate cancer (Asian Population Study). Asia-Pacific Journal of Clinical Oncology. 20(5). 572–581. 7 indexed citations
10.
Wilkinson, Kate, Bin Wang, Xiaojuan Wu, et al.. (2023). KRAS and BRAF Mutation Rates and Survival Outcomes in Colorectal Cancer in an Ethnically Diverse Patient Cohort. International Journal of Molecular Sciences. 24(24). 17509–17509. 5 indexed citations
12.
Ding, Pei Ni, Therese M. Becker, Victoria Bray, et al.. (2019). The predictive and prognostic significance of liquid biopsy in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: A prospective study. Lung Cancer. 134. 187–193. 33 indexed citations
13.
Chua, Wei, et al.. (2019). Spectrum of computed tomography manifestations of appendiceal neoplasms: acute appendicitis and beyond. Singapore Medical Journal. 60(4). 173–182. 9 indexed citations
14.
Souza, Paul de, Wei Chua, Stephen Clarke, David Goldstein, & Chee Khoon Lee. (2016). Inflammatory Markers Have a Role in Renal Cell Carcinoma Prognosis. European Urology Focus. 2(4). 341–342. 2 indexed citations
15.
Lim, Stephanie, Wei Chua, Weng Ng, et al.. (2015). Predictive and prognostic biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Critical Reviews in Oncology/Hematology. 96(1). 67–80. 37 indexed citations
16.
Lim, Stephanie, Therese M. Becker, Wei Chua, et al.. (2013). Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer. Cancer Letters. 346(1). 24–33. 52 indexed citations
17.
Clarke, Stephen, Wei Chua, Melissa M. Moore, et al.. (2011). Use of Inflammatory Markers to Guide Cancer Treatment. Clinical Pharmacology & Therapeutics. 90(3). 475–478. 64 indexed citations
18.
Chua, Wei, Lisa G. Horvath, Philip Beale, & Stephen Clarke. (2011). Reporting clinical trial information: colorectal cancer trials at Sydney Cancer Centre. Internal Medicine Journal. 42(4). 416–421.
19.
Chua, Wei, Matthew Peters, Robert Loneragan, & Stephen Clarke. (2009). Cetuximab-Associated Pulmonary Toxicity. Clinical Colorectal Cancer. 8(2). 118–120. 34 indexed citations
20.
Chua, Wei, Paul Mitchell, F. A. Billson, et al.. (2002). Photographic And Fluorescein Angiographic Outcomes From The Intravitreal Triamcinolone Study For Neovascular Armd. Investigative Ophthalmology & Visual Science. 43(13). 2907–2907. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026